CHE — CHEMED CORP
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 19584 ·
Last close
$488.59
Market Cap
$6.49B
52W High
$493.47
52W Low
$370.49
ADV30
211,840
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 657,513,000 | 215,764,000 | 84,578,000 | 66,302,000 | 1,535,815,000 | 16,856,000 | 687,821,000 |
| Dec 2025 | 639,337,000 | 225,171,000 | 103,563,000 | 76,751,000 | 1,538,189,000 | 74,515,000 | 558,784,000 |
| Sep 2025 | 624,900,000 | 196,907,000 | 74,750,000 | 64,237,000 | 1,623,619,000 | 129,752,000 | 546,936,000 |
| Jun 2025 | 618,798,000 | 184,693,000 | 69,002,000 | 52,493,000 | 1,717,847,000 | 249,904,000 | 519,362,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$443,747,000
Investing CF
$-83,455,000
Financing CF
$-517,318,000
CapEx
$-66,631,000
Dividends Paid
$-32,543,000
Buybacks
$-588,317,000
EPS Diluted TTM
$18.35
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$3,013,504,000
Inventory
$7,208,000
Receivables
$215,479,000
ST Investments
—
EBIT TTM
$350,877,000
Pretax Income TTM
$348,944,000
Interest Exp TTM
$1,933,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,540,548,096
EBITDA
$395,072,000
Free Cash Flow
$348,256,736
Enterprise Value
$6,703,641,600
Total Cash
$16,856,000
Total Debt
$236,934,000
Shares Out
13,274,104
Trailing EPS
$18.34
Book Value
$64.15
ROE
25.6%
ROA
12.8%
Div Yield
0.49%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,529,978,000 | 341,155,000 | 265,238,000 | 1,538,189,000 | 558,784,000 | — | 388,272,000 |
| Dec 2024 | 2,431,287,000 | 366,939,000 | 301,999,000 | 1,668,575,000 | 549,582,000 | — | 417,497,000 |
| Dec 2023 | 2,264,417,000 | 342,830,000 | 272,509,000 | 1,668,095,000 | 560,219,000 | — | 330,299,000 |
| Dec 2022 | 2,134,963,000 | 347,187,000 | 249,624,000 | 1,442,012,000 | 643,297,000 | — | 309,886,000 |
TTM Snapshot
Revenues TTM
$2,033,144,000
NetIncome TTM
$268,073,000
OpCashFlow TTM
$0
Assets (Latest)
$1,668,575,000
Forward EPS
$26.88
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PACS | PACS Group, Inc. | $6.84B | $43.22 | — |
| HIMS | Hims & Hers Health, Inc. | $7.67B | $34.38 | — |
| BLLN | BillionToOne, Inc. | $5.25B | $126.77 | — |
| SHC | Sotera Health Co | $5.25B | $18.42 | — |
| CELC | Celcuity Inc. | $5.25B | $107.58 | — |
News headlines (Yahoo Finance, 1h cache)
Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29
2026-07-01 13:00 · Yahoo
Should You Hold Chemed Stock in Your Portfolio Now?
2026-06-26 14:04 · Yahoo
A Look Back at Senior Health, Home Health & Hospice Stocks’ Q1 Earnings: Chemed (NYSE:CHE) Vs The Rest Of The Pack
2026-06-22 20:59 · Yahoo
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
2026-06-18 13:41 · Yahoo
Chemed (CHE) Stock Valuation Check After Recent Mixed Performance And Undervaluation Debate
2026-06-15 16:08 · Yahoo
AVAH or CHE: Which Is the Better Value Stock Right Now?
2026-06-10 15:40 · Yahoo
1 Profitable Stock for Long-Term Investors and 2 We Avoid
2026-06-10 11:37 · Yahoo
Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas
2026-06-08 19:15 · Yahoo
AVAH vs. CHE: Which Stock Is the Better Value Option?
2026-05-25 15:40 · Yahoo
2 Small-Cap Stocks with Solid Fundamentals and 1 We Avoid
2026-05-20 09:32 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.